Cockroach Labs is the New York software company — last valued at roughly $5 billion — behind CockroachDB, a cloud-native distributed SQL database built to keep applications running and data consistent even across regions and through failures. It is one of the most prominent names in modern databases, but as of mid-2026 Cockroach Labs is still private: there is no S-1, no ticker and no IPO price range. This is a “what to watch” breakdown of the Cockroach Labs IPO, plus the publicly traded database and cloud stocks you can actually buy today to play the same theme.
Cockroach Labs IPO Snapshot
| Field | Detail |
|---|---|
| Company | Cockroach Labs, Inc. |
| Proposed Ticker / Exchange | TBD / TBD (not disclosed) |
| IPO Status (Phase) | Private; no public S-1 filed (pre-IPO) |
| Expected Price Range | Not disclosed |
| Last Reported Valuation | ~$5 billion (2021 funding round) |
| Business | CockroachDB distributed SQL database |
| Total Funding Raised | ~$630 million+ (reported) |
| Co-Founders | Spencer Kimball, Peter Mattis, Ben Darnell |
| HQ / Founded | New York City / 2015 |
Figures are from press reporting and private financings, not an audited public prospectus. Cockroach Labs has not filed an S-1; treat all numbers as reported estimates subject to change.
Table of Contents
- Key Takeaways
- What Is Cockroach Labs?
- When Will the Cockroach Labs IPO Happen?
- What We Know About Cockroach Labs’ Business & Economics
- Who Are Cockroach Labs’ Competitors?
- Cockroach Labs IPO: Bull Case vs What to Watch
- How Cockroach Labs Is Priced vs Public Peers
- How to Get Exposure to the Cockroach Labs IPO Theme
- Cockroach Labs IPO FAQs
Key Takeaways
- What it does: Cockroach Labs makes CockroachDB, a distributed SQL database that scales horizontally, survives failures and keeps data consistent across regions — offered as software and a managed cloud service.
- IPO status: The Cockroach Labs IPO is anticipated but unscheduled — the company is private with no S-1, ticker or price range as of mid-2026.
- Key number: Cockroach Labs was last valued around $5 billion in a 2021 round and serves enterprises needing resilient, scalable databases.
- What to watch: Competition from cloud giants and MongoDB, the shift to its managed cloud service, open-source monetization, and the eventual audited financials.
- Exposure angle: You cannot buy Cockroach Labs shares yet; the practical way to trade the database theme is via public peers — MongoDB, Oracle, Snowflake, Amazon and Microsoft.
What Is Cockroach Labs?
Cockroach Labs is a database company founded in 2015 by Spencer Kimball, Peter Mattis and Ben Darnell, former Google engineers, headquartered in New York. Its product, CockroachDB, is a “distributed SQL” database — inspired in part by Google’s Spanner — designed to combine the familiar structure and consistency of traditional SQL databases with the scalability and resilience of modern cloud systems. In plain terms, CockroachDB is built to spread data across many machines and even across regions, so that applications keep running and data stays correct even if servers or whole data centers fail. That combination of reliability, global reach and horizontal scalability targets demanding applications in finance, retail, gaming and other sectors where downtime and data errors are costly.
The thesis behind the Cockroach Labs IPO is that the database market is enormous and shifting toward cloud-native, distributed systems, and that CockroachDB’s architecture fits where modern applications are heading. Cockroach Labs makes money through enterprise licenses for self-managed deployments and, increasingly, through CockroachDB Cloud, its fully managed database-as-a-service, where customers pay based on usage. For anyone searching “what is Cockroach Labs” or “is Cockroach Labs going public,” the short answer is: Cockroach Labs is the company behind the CockroachDB distributed database, and the Cockroach Labs IPO is anticipated but not yet filed.
When Will the Cockroach Labs IPO Happen?
There is no official Cockroach Labs IPO date. As a well-funded, later-stage enterprise-software company, it is often mentioned as an eventual IPO candidate, but as of mid-2026 it has not filed a public S-1, set a price range, named underwriters or announced a timeline. That places it in the earliest pre-IPO phase, where everything about a listing remains speculative.
The key caveat is that the Cockroach Labs IPO is a watch item, not a scheduled event, and the figures in circulation come from private funding rounds rather than audited filings. Its roughly $5 billion valuation was set in 2021, near the peak of the software-funding cycle; valuations for enterprise-software companies have generally reset since, so the mark may not reflect where Cockroach Labs would price today. Timing would likely depend on the company scaling its cloud revenue, demonstrating a path to profitability, and a receptive IPO window for infrastructure software. Until Cockroach Labs files an S-1 with audited financials, the responsible stance is to treat the Cockroach Labs IPO as anticipated but unconfirmed.
What We Know About Cockroach Labs’ Business & Economics
Without a prospectus, Cockroach Labs’ financial picture comes from reporting and company statements and should be read as such. The model has shifted over time from primarily selling licenses for self-managed CockroachDB toward CockroachDB Cloud, its managed service, where customers pay based on consumption. That transition matters: managed cloud services can produce recurring, usage-based revenue that grows as customers’ applications scale, supporting strong net revenue retention, but they also carry the infrastructure costs of running databases on behalf of customers. Cockroach Labs serves demanding enterprise workloads, and the value of reliability and scale can make its database sticky once adopted for critical systems.
What the public numbers do not reveal is the detail investors would need: revenue scale, growth rate, the cloud-versus-license mix, gross margin and profitability. The central tension for the Cockroach Labs IPO is competition and monetization. The database market includes formidable public players and the cloud giants, which offer their own distributed and managed databases, and Cockroach Labs — which has roots in open-source — must convert adoption into paid enterprise and cloud revenue. The bullish read is a differentiated, resilient database riding the shift to cloud-native systems; the cautious read is a company competing against deep-pocketed incumbents and cloud providers in a crowded market. Those open questions are why this analysis offers no buy or sell verdict on an unlisted company.
Who Are Cockroach Labs’ Competitors?
Cockroach Labs competes in databases and data infrastructure, where several rivals are public. MongoDB stock is a closely watched comparable — a modern, independent database company that also monetizes through a managed cloud service (Atlas) and is often the public benchmark for next-generation databases. Oracle stock is the long-dominant database incumbent, with a vast installed base and its own cloud database offerings that Cockroach Labs aims to modernize away from.
Snowflake stock is relevant on the cloud-data side, showing how data platforms scale in public markets, while the cloud giants Amazon stock (with Aurora, DynamoDB and other databases) and Microsoft stock (with Azure SQL and Cosmos DB) both compete directly and, in some cases, host CockroachDB workloads. Google’s Spanner, part of Alphabet, is another distributed-database rival. Together the listed names form a tradeable map of the database and cloud-data theme the Cockroach Labs IPO highlights.
Correlated & Competitor Stocks
| Company (Ticker) | What they do | Why correlated to Cockroach Labs | Approx. price (early Jun 2026) |
|---|---|---|---|
| MongoDB (MDB) | Modern database + Atlas cloud | Closest next-gen database comparable | Triple digits |
| Oracle (ORCL) | Databases & cloud | Dominant incumbent Cockroach challenges | Triple digits |
| Snowflake (SNOW) | Cloud data platform | Cloud-data scaling read-across | Triple digits |
| Amazon (AMZN) | AWS databases (Aurora, DynamoDB) | Cloud-giant database competitor | Triple digits |
| Microsoft (MSFT) | Azure SQL & Cosmos DB | Cloud database rival and host | ~$417 |
Prices are approximate and as of early June 2026; verify the live quote before trading. Google Spanner is accessed via Alphabet’s listing.
Cockroach Labs IPO: Bull Case vs What to Watch
The bull case. Cockroach Labs targets a huge, mission-critical market — databases — with an architecture built for exactly where modern applications are heading: cloud-native, globally distributed and resilient. Once a company runs critical systems on CockroachDB, switching is hard, which makes revenue sticky, and the shift toward its managed cloud service can drive recurring, usage-based growth. Its founders’ Google pedigree and the technical strength of distributed SQL give it credibility with demanding enterprises. If Cockroach Labs scales its cloud business profitably, it has the profile of a durable infrastructure company — the optimistic frame for the Cockroach Labs IPO.
What to watch (rather than a verdict, since Cockroach Labs is private and pre-filing). First, competition: MongoDB, Oracle and the cloud giants all offer distributed or managed databases. Second, the cloud transition and its effect on growth and margins, which a fresh S-1 would reveal. Third, open-source monetization, given the company’s roots. Fourth, profitability and the cost of running a managed database service. Fifth, whether its 2021 valuation holds up in public markets. These are the dynamics to track before the Cockroach Labs IPO becomes investable.
How Cockroach Labs Is Priced vs Public Peers
Because there is no public Cockroach Labs stock, the only yardstick is its last private valuation against listed database and cloud names. At roughly $5 billion (set in 2021), Cockroach Labs would be much smaller than MongoDB, Oracle or Snowflake, and a tiny fraction of Amazon or Microsoft, depending on the day’s prices. MongoDB is the most instructive comparable because it is an independent, modern database company that monetizes heavily through a managed cloud service and discloses the revenue growth, retention and margins public markets use to value this model. The Cockroach Labs IPO valuation will ultimately hinge on its revenue scale, cloud growth and profitability versus these benchmarks.
The honest framing for a Phase-pre-IPO name is “differentiated database with a 2021 price tag.” Software valuations have reset from that peak, and investors scrutinize infrastructure margins and cloud economics closely, so Cockroach Labs’ eventual IPO valuation could land above or below its last private mark depending on conditions and its financials at filing. Until Cockroach Labs publishes audited numbers, there is no responsible buy or sell call to make on it. What investors can do today is decide how much they believe in the database and cloud-data thesis and express that through the listed peers above, where real prices and financials already exist.
One more point of context helps frame the Cockroach Labs IPO realistically: the database market rewards durability, and MongoDB’s public journey is the clearest template for what a Cockroach Labs listing would need to show. MongoDB proved that an independent, modern database company could grow rapidly by shifting customers to a managed cloud service, and public investors reward that recurring, expanding revenue when gross margins hold up. The risk for any such company is that the cloud giants offer their own competing databases and can bundle them with the rest of their platforms. Cockroach Labs must show that its distributed-SQL architecture is differentiated enough that enterprises choose it for critical workloads and expand over time. A public S-1 would reveal whether that is happening through cloud revenue growth, net retention and margins — the figures that would define a Cockroach Labs listing far more than its 2021 private mark.
How to Get Exposure to the Cockroach Labs IPO Theme
To be direct: you cannot buy Cockroach Labs shares before it lists, pre-IPO access is generally limited to institutional and accredited investors, and no listing is confirmed. So for most people the realistic question is not “how do I buy Cockroach Labs stock” but “how do I get exposure to the database theme the Cockroach Labs IPO represents.” The practical answer is the basket of public database and cloud names above — many available as real U.S. shares through US stocks on MEXC.
A theme-based approach spreads the risk: a modern independent database through MongoDB, the incumbent through Oracle, cloud data through Snowflake, and hyperscale database services through Amazon and Microsoft. These names move on the same drivers that will shape Cockroach Labs — enterprise data growth, the shift to cloud-native and distributed databases, and software spending. None is a substitute for owning Cockroach Labs directly, but as a group they let you participate in the database cycle now, with normal liquidity and no allocation lottery. Confirm live prices and size positions to your own risk tolerance; this is information, not a recommendation.
Cockroach Labs IPO FAQs
What does Cockroach Labs do?
Cockroach Labs makes CockroachDB, a distributed SQL database that scales horizontally, survives server and data-center failures, and keeps data consistent across regions, offered both as software and as a managed cloud service.
When is the Cockroach Labs IPO?
No date has been set. As of mid-2026 Cockroach Labs is private with no public S-1, underwriters or price range. An IPO is anticipated given its scale, but it remains a watch item rather than a scheduled event.
Can I buy Cockroach Labs stock before the IPO?
No. Cockroach Labs is private, and pre-IPO shares are generally restricted to institutional and accredited investors. The public will only be able to buy it once (and if) it lists — or get exposure to the theme now through public peers.
What is Cockroach Labs’ valuation?
Cockroach Labs was last valued around $5 billion in a 2021 funding round. That is a private figure from the software-funding peak, so any eventual IPO valuation could differ materially in either direction.
Who are Cockroach Labs’ competitors?
Public competitors and comparables include MongoDB, Oracle, Snowflake, Amazon (AWS databases) and Microsoft (Azure databases). Google’s Spanner, part of Alphabet, is another distributed-database rival.
Disclaimer
This article is for informational purposes only and does not constitute financial advice, an offer to sell, or a solicitation to buy any security. IPO details (price range, valuation, timing) are subject to change and may differ from the final terms. You cannot purchase shares of a company before it lists, and IPO allocations are not guaranteed. Past performance does not guarantee future results. Investors should read the company’s official SEC filings and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.